on Nanohale AG (ETR:FYB)
Formycon Schedules Conference Call and Participation in Investor Conferences
Formycon AG, a German biopharmaceutical company, plans to release its 2026 half-year results on August 12. The Management Board will hold a conference call to discuss the company's progress, financial metrics, and provide future forecasts. The call will be broadcast in English at 3:00 PM CEST. Interested participants are required to register online to receive dial-in details.
In addition to the results announcement, Formycon's executives will participate in various international investor conferences. These events include the H.C. Wainwright Global Investment Conference in New York and the Jefferies London Healthcare Conference, among others.
Formycon continues to engage with investors and stakeholders, emphasizing transparency and dialogue as they advance their biosimilar product portfolio. For access to the live broadcast and more information, visit Formycon's investor relations webpage.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Nanohale AG news